StreetAlpha
Cartesian Therapeutics, Inc. · SEC Form 4

RNAC Insider Trading

From SEC Form 420 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of Cartesian Therapeutics, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are net sellers over the last 12 months: $206K bought and $259K sold.

← RNAC stock page

Insiders are net sellers
Bought, 12 months$206K1 buys · 1 insiders
Sold, 12 months$259K3 sales · 3 insiders
Net−$53Kbought minus sold
Planned sales–of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
2025-12: bought $206KDec2026-01: sold $259KJanFebMarAprMayJunJulAugSepOctNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when RNAC insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an RNAC officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every RNAC insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Jan 6, 2026Blaine DavisCFOSale10,591$6.82$72K121,220Jan 8Form 4
Jan 6, 2026Milos MiljkovicChief Medical OfficerSale3,573$6.82$24K58,820Jan 8Form 4
Jan 6, 2026Carsten BrunnPresident and CEOSale23,766$6.82$162K323,530Jan 8Form 4
Dec 4, 2025Timothy C BarabeDirectorBuy30,000$6.86$206K54,366Dec 8Form 4
Apr 11, 2025Timothy A SpringerDirectorBuy149,075$10.21$1.5M656,513Apr 11Form 4
Mar 20, 2025Timothy A SpringerDirectorBuy89,863$15.26$1.4M8,621,325Mar 20Form 4
Jan 14, 2025Timothy A SpringerDirectorBuy20,967$17.47$366K8,531,462Jan 15Form 4
Jan 6, 2025Blaine DavisCFOSale7,989$16.78$134K94,811Jan 7Form 4
Jan 6, 2025Carsten BrunnPresident and CEOSale17,271$16.78$290K204,096Jan 7Form 4
Jan 6, 2025Emily EnglishChief Operations OfficerSale1,797$16.78$30K40,226Jan 7Form 4
Jan 6, 2025Christopher M JewellChief Scientific OfficerSale2,550$16.78$43K53,490Jan 7Form 4
Jan 6, 2025Milos MiljkovicChief Medical OfficerSale1,880$16.78$32K35,393Jan 7Form 4
Jan 6, 2025Metin KurtogluChief Technology OfficerSale4,875$16.78$82K62,258Jan 7Form 4
Dec 23, 2024Timothy A SpringerDirectorBuy52,189$18.49$965K8,507,895Dec 23Form 4
Dec 10, 2024Metin KurtogluChief Technology OfficerSale13,664$25.26$345K51,033Dec 11Form 4
🔒 5 more trades. Create a free account or sign in to see them all.

RNAC insider trading FAQ

Are RNAC insiders buying or selling?

Insiders are net sellers over the last 12 months. 1 insiders bought $206K of RNAC on the open market in 1 trades, and 3 sold $259K in 3 trades.

When did an RNAC insider last buy shares?

Timothy C Barabe (Director) bought 30,000 shares for $206K on Dec 4, 2025, reported on Dec 8, 2025.

When did an RNAC insider last sell shares?

Blaine Davis (CFO) sold 10,591 shares for $72K on Jan 6, 2026.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice